Accelerated Rule Out of Myocardial Infarction

NACompletedINTERVENTIONAL
Enrollment

4,516

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

October 3, 2019

Study Completion Date

September 3, 2020

Conditions
Myocardial Infarction
Interventions
PROCEDURE

Accelerated, combined biomarker rule-out strategy for MI

Blood sample is acquired while the patient is in the ambulance. This is brought to hospital and handed over to the laboratory personnel for acute analysis for copeptin level. At arrival to hospital, a second blood sample is acquired and analyzed for high-sensitive cardiac troponin-T(hs-cTnT). Answers of these analyzes are in-hand with-in 60 minutes. If copeptin in the pre-hospital blood sample is \<9,8 pmol/L (95% percentile) AND hs-cTnT in the in-hospital blood sample is \<14ng/L (99% percentile), then myocardial infarction can be ruled out, and depending of clinical presentation, the patient can be discharged.

Trial Locations (3)

8200

Department of Cardiology, Aarhus University Hospital, Aarhus

8700

Department of Internal Medicine, Horsens Regional Hospital, Horsens

8800

Department of Cardiology, Viborg Regional Hospital, Viborg

All Listed Sponsors
lead

Aarhus University Hospital Skejby

OTHER

NCT02666326 - Accelerated Rule Out of Myocardial Infarction | Biotech Hunter | Biotech Hunter